Pharming Group N.V. (PHAR) Assets Average (2023 - 2024)
Pharming (PHAR) has disclosed Assets Average for 2 consecutive years, with $1.7 billion as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Assets Average rose 6.43% year-over-year to $1.7 billion, compared with a TTM value of $1.7 billion through Dec 2024, up 6.43%, and an annual FY2024 reading of $431.4 million, down 2.9% over the prior year.
- Assets Average was $1.7 billion for Q4 2024 at Pharming, up from $1.6 billion in the prior quarter.
- Across five years, Assets Average topped out at $1.7 billion in Q4 2024 and bottomed at $1.6 billion in Q4 2023.